Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of the Unaudited Financial Results of the Company for the quarter ended 30th June 2025
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed the exchanges about the newspaper publication of its unaudited financial results for the quarter ended 30 June 2025, as required under SEBI LODR Regulation 47. The Board of Directors had approved these results at its meeting held on 13 August 2025. The results were advertised in Active Times (15 August 2025) and Mumbai Lakshadeep (16 August 2025), and also uploaded on the company's website. The published figures show total income from operations of Rs. 10,376 lakhs for Q1 FY26 versus Rs. 12,848.71 lakhs in Q1 FY25, with profit after tax of Rs. 172.82 lakhs (up from Rs. 133.08 lakhs) and EPS of Rs. 0.48 versus Rs. 0.44 year-on-year.
This is a routine regulatory compliance filing confirming that the company's Q1 FY26 results have been publicly disseminated through newspapers. The underlying results show a year-on-year decline in revenue but an improvement in profitability and EPS. No new material information is being disclosed beyond what was already shared when the Board approved the results.